Entity Addresses, Address Type [Axis] Business Contact [Member] Classes of share capital [axis] Ordinary Shares, par value CHF 100/11325 per share Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share Ordinary Share [Member] Warrant To Purchase [Member] Legal Entity [Axis] Veraxa Biotech Holding A G [Member] Components of equity [axis] Subscribed Capital [Member] Retained Earning [Member] Total Equity [Member] Veraxa Biotech A G [Member] Capital Reserves [Member] O C I [Member] Classes of property, plant and equipment [axis] Furniture And Fixtures [Member] I T Systems [Member] Leasehold Improvement [Member] Industrial Property Rights [Member] Capitalized Development Costs [Member] Technology [Member] Furniture [Member] Machines [Member] Vehicle [Member] Assets Under Construction [Member] Classes of intangible assets other than goodwill [axis] Goodwills [Member] In Process R And D Flysin [Member] Trademark Rights [Member] Software [Member] Maturity [axis] One Year [Member] Two Years [Member] Three Years [Member] Four Years [Member] Levels of fair value hierarchy [axis] Level 3 Of Fair Values Hierarchy [Member] Classes of liabilities [axis] S A Rs Liability [Member] Contingent Liability [Member] Entity Addresses [Table] Entity Addresses [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, City or Town Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Contact Personnel Name ICFR Auditor Attestation Flag Document Financial Statement Error Correction [Flag] Auditor Name Auditor Location Auditor Firm ID Entities [Table] Entity Information [Line Items] ASSETS Cash Total Assets LIABILITIES AND EQUITY Accrued expenses Due to related party Advances-related parties Total liabilities EQUITY Subscribed Capital Accumulated deficit Total shareholder’s deficit TOTAL LIABILITIES AND EQUITY Formation expenses General and administrative expenses Net loss Weighted-average shares outstanding, basic Weighted-average shares outstanding, diluted Basic earnings per share Diluted earnings per share Statement of changes in equity [table] IfrsStatementLineItems [Line Items] Balance, June 25, 2025 (inception) Beginning balance, shares Initial contribution of capital Initial contribution of capital, shares Net loss Ending balance, value Ending balance, shares CASH FLOWS FROM OPERATING ACTIVITIES: Adjustments to reconcile net loss to net cash provided by operating activities: Accrued Expenses Due to related party Advances-related parties Net cash provided by operating activities CASH FLOWS FROM FINANCING ACTIVITIES: Proceeds from initial capital contribution Net cash provided by financing activities NET CHANGE IN CASH Cash, beginning of period Cash, end of period Property and equipment, net Goodwill Intangible assets, net Right-of-Use lease assets Other receivables - Long term Total non-current assets Other receivables Other receivables - related party Prepaid expenses and other current assets Cash and cash equivalents Total current assets Equity and liabilities Equity Subscribed capital Capital reserve Other reserve Noncurrent lease liabilities Deferred tax liabilities Contingent liabilities Remuneration commitments (SARs) Total non-current liabilities Accounts payable Current lease liabilities Notes payable - related parties Other current liabilities Total current liabilities Revenue Cost of goods sold Gross profit General and administrative expenses Research and development expenses Sales and marketing expenses Depreciation and amortization expenses Operating loss Change in fair value of contingent liabilities Currency exchange gain (loss) Other income Finance expenses Loss before taxes Tax benefit Foreign operations - currency translation differences Total reclassifiable amounts Comprehensive Loss Loss for the period Other result - currency conversion Share based compensation in relation to ESOP Proceeds from the issuance of share capital Cost of share issuance Share capital issued in connection with acquisitions Depreciation and amortization Share-based compensation expense Non cash lease expense Interest paid on lease liabilities Change in fair value of contingent liabilities Loss on disposal of assets Unrealized loss(gain) on foreign currency translation Other non-cash transactions Accounts payable Accrued expenses Prepaid expenses and other current assets Other receivables Other receivables, related party Other assets Deferred taxes Other current liabilities Purchase of property, plant and equipment Cash flow used in investing activities Proceeds from the issue of equity instruments of the company, net of transaction costs Proceeds from the issuance of notes payable - related parties Payment of principal portion of lease liabilities Supplemental cash flow disclosures: Initial recognition of lease liability and right-of-use asset Description of Organization and Business Operations Significant Accounting Policies Related Party Transactions Share Capital Subsequent Events General information, functional and presentation currency Summary of material accounting policies Personnel expenses Property and equipment Intangible assets and goodwill Leases Accrued expenses Income taxes recognized in the income statement Deferred taxes Share capital Transactions with related parties Disclosures on financial instruments Capital risk management Fair value measurement Loss per share Commitments and contingencies Segment disclosures Events Occurring After the Reporting Date Basis of Presentation Use of Estimates Cash Income Taxes Ordinary shares Loss Per Share Fair Value measurement Recently issued accounting standards Basis of consolidation Liquidity and Capital Resources Foreign Currency Transactions and Translation Fair value measurement Cash and cash equivalents Property, plant and equipment Intangible assets and Goodwill Income taxes Transactions with related parties Leases General and Administrative expenses Research and development expenses Sales and marketing expenses Share-Based Compensation – Share Appreciation Rights (“SARs”) Critical Accounting Estimates and Judgments Segment Reporting New and amended standards and interpretations Schedule of straight-line method over a useful life Schedule of estimated useful life Schedule of expenses for employee benefits Schedule of VSOP share activity Schedule of property and equipment Schedule of intangible assets and goodwill Schedule of weighted-average discount rate Schedule of summarizes the maturities Schedule of accrued expenses Schedule of operating activities Schedule of tax expense income for the financial year Schedule of deferred tax assets Schedule of carry voting rights Schedule of foreign currency translation reserves Transactions with related parties Schedule of financial instruments Schedule of liabilities that are measured at fair value on a recurring basis Schedule of assumptions used in valuing the SARs and contingent liability Schedule of antidilutive due to the loss incurred for the periods Schedule of contribute to the assessment of segment performance Overpayment of the initial capital contribution PubCo shares issued PubCo par value PubCo value issued Assets totaling Liabilities totaling Initial share capital Previously shares Share split Ordinary capital increase New total share capital Issued of exchange shares Shareholders in exchange shares Exchange ratio Maximum capital increase Issuance of new shares Capital Band Additional shares Disclosure of detailed information about property, plant and equipment [table] Amortization Useful life Profit (loss) Cash flows from (used in) operating activities Working capital deficit Retained earnings Salaries IFRS 2 - Share-based payment on virtual options IFRS 2 - Share-based payment on employee stock options Social expenses Other personnel expenses Total expenses for employee benefits Number of VSOP shares at beginning Number of VSOP shares, commitments Number of VSOP shares, forfeited Number of VSOP shares, cancelled Number of VSOP shares at ending Number of VSOP shares issued Number of shares issued share based compensation expense General and administrative expenses Property and equipment, beginning Additions Transfer Additions FX Effects Property and equipment, ending Accumulated depreciation at beginning Depreciation for the year Depreciation for the year Accumulated depreciation at beginning Accumulated depreciation at ending Property and equipment net Disclosure of detailed information about intangible assets [table] Intangible assets and goodwill, beginning Disposals FX effects Additions Intangible assets and goodwill, ending Accumulated depreciation at beginning Amortization for the year Disposals Accumulated depreciation at ending Intangible assets and goodwill net Weighted average remaining lease term Weighted average discount rate 2029 Total expected lease payments Less: imputed interest Total lease liability Less: current lease liability Non-current lease liability Personnel expenses Tax provision (incl. emission levies on capital band) Xlife share lending accrual Other Total accrued expenses Cash outflow for leases Payment of principal portion of lease liabilities Interest paid on lease liabilities. Right-of-use assets and lease liabilities Income tax income/expense in the current financial year Recognized deferred (tax expense)/tax income Reported tax income for the current period Earnings before income taxes Income tax expense at a tax rate of 31% Amortization of deferred tax assets due to derecognition Effects of non-tax-deductible expenses and income Effects of results for which no deferred taxes were recognized Effects of losses for which deferred tax assets were recognized Tax rate differences Tax amount recognized in the income statement Tax losses (Switzerland) Tax losses (Germany) Total unrecognized deferred tax assets (expiring until 2028) Possible tax effect Capital increase expenses Balancing Balance sheet recognition of deferred tax assets Intangible assets from addition Veraxa Biotech GmbH Intangible assets from addition Synimmune GmbH Amortization of intangible assets Gross amount of deferred tax liabilities Balancing Balance sheet recognition of deferred tax liabilities Share capital balance as of year end Changes in the reporting year Share capital balance as of year end Capital band (Article 3b) Conditional share capital (Article 3a) Other receivables - Xlife Other receivables - related party (Veraxa Biotech Holding AG) Notes payable - Xlife Prepaid benefit receipt Aggregate amount Ordinary shares Owned shares Principal amount Financial assets measured at amortized cost Financial liabilities measured at amortized cost Disclosure of fair value measurement of assets [table] Fair value liability, beginning Share based compensation Fair value adjustment Fair value liability, ending Stock price Volatility Risk free rate of retturn Expected term (in years) Weighted average cost of capital Numerator: Net loss available to common shareholders Denominator: Gross profit Depreciation and amortization expenses Operating loss Aggregate exercise price Initial exercise price Entity Address, Country Assets Liabilities Equity Equity and liabilities ShareOutstanding IncreaseDecreaseInDueToRelatedParty IncreaseDecreaseInAdvancesrelatedParties Cash flows from (used in) operating activities Cash flows from (used in) financing activities Increase (decrease) in cash and cash equivalents before effect of exchange rate changes Non-current assets Current assets Non-current liabilities Current liabilities Cost of sales Research and development expense Sales and marketing expense DepreciationAndAmortizationExpenses FinanceExpenses Profit (loss) before tax Tax expense (income) Share issue related cost UnrealizedLossgainOnForeignCurrencyTranslation AccountsPayable AccruedExpense PrepaidExpensesAndOtherCurrentAssets OtherReceivable OtherReceivableRelatedParty OthersAssets DeferredTaxes OthersCurrentLiabilities Purchase of property, plant and equipment, classified as investing activities Cash flows from (used in) investing activities Disclosure of accrued expenses and other liabilities [text block] Description of accounting policy for restricted cash and cash equivalents [text block] Description of accounting policy for leases [text block] ScheduleOfLoansToOrFromRelatedCompaniesTableTextBlock NumberOfVsopShares Administrative expenses Property, plant and equipment [Default Label] Disposals, property, plant and equipment AccumulatedDepreciationPropertyPlantAndEquipment Intangible assets and goodwill [Default Label] AdditionsIntangibleAssetsAndGoodwill AccumulatedDepreciationIntangibleAssetsAndGoodwill AccumulatedDepreciationDisposals PersonnelExpenses Deferred tax assets Issued capital OrdinaryShares Financial liabilities, at fair value DepreciationAndAmortisationExpenses